Discovery of the Novel HLA‐DRB3*01:01:25 Allele Using PacBio Sequencing
HLA · 2026-04 · 107 (4)
DOI: 10.1111/tan.70729 ↗Kurz gefasst
Fachartikel in der Zeitschrift HLA, online erschienen am 21.04.2026. Verfasst von Wenqian Song und 4 weiteren Autor:innen. Beteiligte Einrichtung: Dalian Blood Center, Dalian, Liaoning, China. Hauptthemen laut MEDLINE: Alleles, Exons, HLA-DRB3 Chains, Sequence Analysis, DNA. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 2 Literaturangaben. Gefördert von: Dalian Science and Technology Innovation Fund.
Abstract (Originalsprache)
HLA‐DRB3*01:01:25 differs from DRB3*01:01:02:08 by one nucleotide substitution in exon 2, and intronic changes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Dalian Blood Center, Dalian, Liaoning, China.
- College of Laboratory Medicine, Dalian Medical University, Dalian, China.
ORCID-Profile: Wenqian Song, Shihang Zhou, Xiaohua Liang
Förderung
- Dalian Science and Technology Innovation Fund
Zitieren
APA
Song, W., Yu, W., Bai, S., Zhou, S., & Liang, X. (2026). Discovery of the Novel HLA‐DRB3*01:01:25 Allele Using PacBio Sequencing. HLA, 107(4). https://doi.org/10.1111/tan.70729
Vancouver
Song W, Yu W, Bai S, Zhou S, Liang X. Discovery of the Novel HLA‐DRB3*01:01:25 Allele Using PacBio Sequencing. HLA. 2026;107(4). doi:10.1111/tan.70729
BibTeX
@article{Song2026,
author = {Song, Wenqian and Yu, Wanzhen and Bai, Suning and Zhou, Shihang and Liang, Xiaohua},
title = {Discovery of the Novel HLA‐DRB3*01:01:25 Allele Using PacBio Sequencing},
journal = {HLA},
year = {2026},
volume = {107},
number = {4},
doi = {10.1111/tan.70729}
}
EUVIMED